C. Lackner

1.2k total citations · 1 hit paper
15 papers, 785 citations indexed

About

C. Lackner is a scholar working on Epidemiology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, C. Lackner has authored 15 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Pathology and Forensic Medicine and 6 papers in Oncology. Recurrent topics in C. Lackner's work include Liver Disease Diagnosis and Treatment (8 papers), Alcohol Consumption and Health Effects (4 papers) and Pancreatic and Hepatic Oncology Research (2 papers). C. Lackner is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Alcohol Consumption and Health Effects (4 papers) and Pancreatic and Hepatic Oncology Research (2 papers). C. Lackner collaborates with scholars based in Austria, United States and Germany. C. Lackner's co-authors include Helena Cortez‐Pinto, Laurent Spahr, Martina Sterneck, Mark Thursz, Antoni Gual, Philippe Mathurin, Christophe Moreno, Rajeshwar P. Mookerjee, Vanessa Stadlbauer and Rajiv Jalan and has published in prestigious journals such as Hepatology, Journal of Hepatology and Current Pharmaceutical Design.

In The Last Decade

C. Lackner

15 papers receiving 769 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EASL Clinical Practice Guidelines: Management of alcohol-related liver disease

2018 561 citations Mark Thursz, Antoni Gual et al. Journal of Hepatology profile →

Peers

Countries citing papers authored by C. Lackner

Since Specialization

Citations

This map shows the geographic impact of C. Lackner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Lackner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Lackner more than expected).

Fields of papers citing papers by C. Lackner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Lackner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Lackner. The network helps show where C. Lackner may publish in the future.

Co-authorship network of co-authors of C. Lackner

This figure shows the co-authorship network connecting the top 25 collaborators of C. Lackner. A scholar is included among the top collaborators of C. Lackner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Lackner. C. Lackner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Aramchol improves hepatic fibrosis in metabolic dysfunction–associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathology 2024 ·Hepatology ·Vlad Ratziu, Yusuf Yılmaz, (unknown), Scott L. Friedman, C. Lackner, Cynthia Behling, Oscar W. Cummings, (unknown), (unknown), Yossi Gilgun‐Sherki, Tali Gorfine, Shaul Kadosh, Eli Eyal, Arun J. Sanyal	11
2	Nonalcoholic Fatty Liver Disease versus Alcohol-related Liver Disease: Is it Really so Different? 2020 ·Current Pharmaceutical Design ·(unknown), C. Lackner, Helena Cortez‐Pinto	12
3	EASL Clinical Practice Guidelines: Management of alcohol-related liver disease breakdown → 2018 ·Journal of Hepatology ·Mark Thursz, Antoni Gual, C. Lackner, Philippe Mathurin, Christophe Moreno, Laurent Spahr, Martina Sterneck, Helena Cortez‐Pinto	561
4	Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer 2018 ·Wiener klinische Wochenschrift ·(unknown), Joanna Szkandera, (unknown), (unknown), Tatjana Stojaković, Peter Kornprat, C. Lackner, Thomas Winder, Konstantin Schlick, Herbert Stöger, Armin Gerger, Martin Pichler, Michael Stotz	2
5	Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer 2018 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), Florian Posch, (unknown), Joanna Szkandera, Konstantin Schlick, Tatjana Stojaković, Peter Kornprat, C. Lackner, Armin Gerger, Herbert Stoeger, Michael Stotz, Martin Pichler	11
6	Intestine‐Specific Overexpression of Carboxylesterase 2c Protects Mice From Diet‐Induced Liver Steatosis and Obesity 2018 ·Hepatology Communications ·(unknown), (unknown), (unknown), Sandra Eder, Kathrin A. Zierler, Ulrike Taschler, Stephanie Kolleritsch, Thomas O. Eichmann, Gabriele Schoiswohl, Christina Leopold, (unknown), C. Lackner, Thomas Rülicke, (unknown), Dagmar Kratky, Tarek Moustafa, Gerald Höefler, Guenter Haemmerle	29
7	Primary Liver Injury and Delayed Resolution of Liver Stiffness after Alcohol Detoxification in Heavy Drinkers with the PNPLA3 Variant I148M 2016 ·Journal of Hepatology ·Vanessa Rausch, Teresa Peccerella, C. Lackner, Eray Yagmur, (unknown), Thomas Longerich, Stefan O. Mueller	1
8	Contribution of Keratin-18 on steatohepatitis and liver cancer 2012 ·Zeitschrift für Gastroenterologie ·Kira Bettermann, (unknown), (unknown), Clemens Diwoky, Andrea Thüringer, Heimo Müller, (unknown), Cornelia Stumptner, Thomas Kolbe, (unknown), Helmut Denk, C. Lackner, Kurt Zatloukal, Johannes Haybaeck	3
9	Ursodeoxycholic Acid for Treatment of Fatty Liver Disease and Dyslipidemia in Morbidly Obese Patients 2011 ·Digestive Diseases ·Hanns–Ulrich Marschall, Martin Wagner, Gernot Zollner, Peter Fickert, C. Lackner, Anders Thorell, Michael Trauner	7
10	The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis 2011 ·Journal of Hepatology ·Rajeshwar P. Mookerjee, C. Lackner, Rudolf Stauber, Vanessa Stadlbauer, (unknown), Ariane Aigelsreiter, Rajiv Jalan	102
11	Compound heterozygosity for two MSH6 mutations in a patient with early onset colorectal cancer, vitiligo and systemic lupus erythematosus 2008 ·American Journal of Medical Genetics Part A ·Nils Rahner, Gerald Höefler, Christoph Högenauer, C. Lackner, Verena Steinke, (unknown), Waltraut Friedl, Stefan Aretz, Peter Propping, Elisabeth Mangold, Constanze Walldorf	34
12	[705] KERATIN IMMUNOSTAINING AS OBJECTIVE MARKER OF HEPATOCYTE BALLOONING IN STEATOHEPATITIS 2007 ·Journal of Hepatology ·C. Lackner, Kurt Zatloukal, Cornelia Stumptner, Helmut Denk	1
13	Critical issues in the identification and management of patients with hereditary non-polyposis colorectal cancer 2005 ·European Journal of Gastroenterology & Hepatology ·C. Lackner, Gerald Höefler	7
14	A Phase II Trial of Weekly High-Dose Folinic Acid and 5-Fluorouracil in Combination with Epirubicin as Salvage Chemotherapy in Advanced Breast Cancer 1994 ·Oncology ·Herbert Stöger, Marianne Schmid, Thomas Bauernhofer, (unknown), F. Ploner, (unknown), (unknown), I. Kuss, M. Wilders‐Truschnig, C. Lackner, P. Steindorfer, H. Samonigg	3
15	Wert und Ergebnisse der Computertomographie bei Pankreaserkrankungen 1979 ·RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren ·Ulrich Mödder, (unknown), E. Bücheler, Edward Baert, C. Lackner, (unknown), (unknown), N Rupp, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact